Revolution Medicines, Inc. (RVMD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Revolution Medicines, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Revolution Medicines, Inc. (RVMD) has returned 22.10% so far this year and 175.03% over the past 12 months.

Based on dividend-adjusted daily data since Feb 13, 2020, RVMD's average daily return is +0.16%, while the average monthly return is +2.89%. At this rate, your investment would double in approximately 2.0 years.

Historically, 59% of months were positive and 41% were negative. The best month was Nov 2020 with a return of +44.5%, while the worst month was Mar 2020 at -29.9%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 4 months.

On a daily basis, RVMD closed higher 51% of trading days. The best single day was Jan 7, 2026 with a return of +28.6%, while the worst single day was Oct 23, 2023 at -34.4%.

Revolution Medicines, Inc. has an annualized alpha of 30.05%, beta of 1.10, and R² of 0.13 versus S&P 500 Index. Calculated based on daily prices since February 14, 2020.

• This stock captured 129.69% of S&P 500 Index gains but only 91.27% of its losses — a favorable profile for investors.
• R² of 0.13 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

RVMD ranks 96 for risk / return — in the top 96% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Revolution Medicines, Inc. (RVMD) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Revolution Medicines, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Revolution Medicines, Inc. was 73.29%, occurring on May 12, 2022. Recovery took 622 trading sessions.

The current Revolution Medicines, Inc. drawdown is 21.11%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Revolution Medicines, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Revolution Medicines, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.